| AIS | Acute ischemic stroke |
| ART | Antiretroviral therapy |
| BPaL | Bedaquiline, linezolid, and pretomanid |
| BMI | Body mass index |
| DALY | Disability-adjusted life year |
| CNS | Central nervous system |
| XDR-TB | Extensively drug-resistant tuberculosis |
| EPTB | Extrapulmonary tuberculosis |
| IRIS | Immune reconstitution inflammatory syndrome |
| IFN-γ | Interferon-gamma |
| IL-2 | Interleukin-2 |
| IL-10 | Interleukin-10 |
| INSHI | International Network for the Study of HIV-associated IRIS |
| HAART | Highly active antiretroviral therapy |
| HIV | Human immunodeficiency virus |
| HIV+ | HIV positive |
| LTBI | Latent tuberculosis infection |
| MLR | Monocyte-to-lymphocyte ratio |
| MDR-TB | Multi-drug-resistant tuberculosis |
| Mtb | Mycobacterium tuberculosis |
| NPV | Negative predictive value |
| NF-kB | Nuclear factor-kB |
| NFAT | Nuclear factor of activated T cells |
| NRTI | Nucleoside reverse transcriptase inhibitor |
| PPV | Positive predictive value |
| PTB | Pulmonary tuberculosis |
| TDF | Tenofovir disoproxil fumarate |
| TST | Tuberculin skin test |
| TB | Tuberculosis |
| TBM | Tuberculosis meningitis |
| TNF | Tumor necrosis factor |
| WHO | World Health Organization |
| XPHACTOR | “Xpert for people attending HIV/AIDS care: or review?” |